237 
0 Kommentare
Heidelberg Pharma AG Boosts Outlook: Exciting New Guidance Revealed!
Heidelberg Pharma AG is steering its financial ship with precision, honing in on cost-saving strategies for 2025. The company has revised its sales and income expectations to a more conservative EUR 7.5-9 million. Operating expenses are trimmed to EUR 36-40 million, with EBIT forecasts now at EUR -28.5 to -31 million. Remarkably, cash needs have plummeted to EUR 14-17 million, a stark contrast to previous estimates. With financing secured until mid-2026, Heidelberg Pharma is poised for a financially stable future.
- Heidelberg Pharma AG has updated its financial guidance for the fiscal year 2025 due to a focus on cost-saving measures.
- Expected sales and other income for 2025 are now projected to be between EUR 7.5 million and EUR 9 million, down from EUR 9 million to EUR 11 million.
- Operating expenses are anticipated to range from EUR 36 million to EUR 40 million, reduced from the previous estimate of EUR 40 million to EUR 45 million.
- The expected operating result (EBIT) is now between EUR -28.5 million and EUR -31 million, compared to the earlier forecast of EUR -30 million to EUR -35 million.
- Cash requirements for 2025 are estimated at EUR 14 million to EUR 17 million, significantly lower than the previously anticipated EUR 50 million to EUR 55 million.
- Heidelberg Pharma's financing is secured until mid-2026 based on current planning and available funds.
The next important date, Publication of Quarterly Financial Report (as of Q3), at Heidelberg Pharma is on 09.10.2025.
The price of Heidelberg Pharma at the time of the news was 3,1350EUR and was up +0,48 % compared with the previous day.
4 minutes after the article was published, the price was 3,1100EUR this corresponds to a minus of -0,80 % since
publication.
Diskutieren Sie über die enthaltenen Werte
Disclaimer für Finanznachrichten mit KI-Autor "wO newsflash" Die bereitgestellten Artikel wurden mit Hilfe einer künstlichen Intelligenz erstellt und dienen ausschließlich Informationszwecken. Die Richtigkeit der Informationen kann nicht garantiert werden. Vor finanziellen Entscheidungen unbedingt unabhängige Quellen konsultieren. Wir übernehmen keine Haftung für Verluste oder Schäden. Investieren birgt Risiken. Keine Empfehlungen zum Kauf oder Verkauf von Finanzprodukten. Urheberrechtlich geschützt, keine Reproduktion ohne Genehmigung. Technische Fehlfunktionen sind jederzeit möglich. Änderungen vorbehalten.
URL kopieren
Per E-Mail teilen
Artikel drucken